余蓉 - 四川大学 - 华西药学院

个人简介

1978．9-1982.7 在华西医科大学药学专业理科学士学位， 1983.6～1984.6 中国协和医科大学&中国医学科学院学习。 2004．9～2007年.10中国药科大学微生物与生化药学专业博士学位 2007.3-2007.8 国家留学及基金委公派高级研究学者赴美留学。 1982.7～1998.6 中国协和医科大学&中国医学科学院输血研究所任实习研究员、助理研究员、副研究员、研究员。 1999年4月至今，四川大学华西药学院任教，博士生及硕士生导师，

研究领域

1. 基因工程药物的研究 2. 天然生化药物（包括微生物药物）的研究 3. 蛋白质工程药物的设计

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Gao Ling，Zhang Chun，Li Lingling，Liang Lan，Deng Xuan，Wu Wutong，Su Zhiguo， Yu Rong*, Construction, Expression and Refolding of a Bifunctional Fusion Protein Consisting of C-Terminal 12-Residue of Hirudin-PA and Reteplase，Protein Journal， 2012，31（4）：328~336 2. Pi-Ping Lv, Yu-Feng Ma, Rong Yu, Hua Yue, De-Zhi Ni, Wei Wei,* and Guang-Hui Ma Targeted Delivery of Insoluble Cargo (Paclitaxel) by PEGylate Chitosan Nanoparticles Grafted with Arg-Gly-Asp (RGD) Molecular Pharmaceutics 2012 , 9 (6) :1736-1747 3.Xiang Silong，Ma Yuyuan* ，Yan Qipo，Lv Maomin，Zhao Xiong，Yin Huiqiong， Zhang Nian，Jia Junting， Yu Rong*，Zhang, Jingang， Construction and characterization of an infectious replication competent clone of porcine endogenous retrovirus from Chinese miniature pigs， Virology Journal，2013，10 ：228 4.Zhang Chun，Liu Yongdong(*)，Zhao Dawei，Li Xiunan, Yu Rong* ,Su Zhiguo, Facile purification of Escherichia coli expressed tag-free recombinant human tumor necrosis factor alpha from supernatant，Protein Expression and Purification， 2014，95：195~203 5.Cai Yingting，Bao Jingxiao，Lao Xingzhen(*) ，Zheng Heng，Chen Jianhua， Yu Rong*, Computational design, functional analysis and antigenic epitope estimation of a novel hybrid of 12 peptides of hirudin and reteplase，Journal of Molecular Modeling， 2015， 21（9）；299 6.Li Yaqiong，Li Xiunan (*)，Chen Chao，Zhao Dawei，Su Zhiguo，Ma Guanghui， Yu Rong* , A rapid, non-invasive and non-destructive method for studying swelling behavior and microstructure variations of hydrogels，Carbohyd rate Polymers，2016.10.20，151：1251~1260 7.Shuang Yin，Chun Zhang Zenglan Li Qi Wang HongShi，RongYu * YongdongLiu，Zhiguo Su I dentification, characterization, and stabilization of the deamidation degradation of recombinant human tumor necrosis factor-α Process Biochemistry , 2016 , 53，3216-223 8.Zhang Chun, Yu Rong * ZenglanLi, CuiFeng, Qi Wang,Yongdong Liu, Zhiguo Su Development of long-acting ciliary neurotrophic factor by site-specific conjugation with different-sized polyethylene glycols and transferrin International Journal of Pharmaceutics 2017, 529(1–2), 275-284 9.Yaqiong Li，Xiunan Li * ，Chao Chen，Dawei Zhao，Zhiguo Su，Guanghui, Ma， Rong Yu* , Sol–gel transition characterization of thermosensitive hydrogels based on water mobility variation provided by low field NMR，Journal of Polymer Research， 2017. 4， 24（25）： 25 10.Liu Liping. Zhang Chun (co-first), Liu Yongding, Yu Rong *, Zhiguo Su et al. Albumin binding domain fusing R/K-X-X-R/K sequence for enhancing tumor delivery of the (6-maleimidocaproyl)-hydrazone derivative of doxorubicin. Molecular Pharmaceutics. 2017. (Manuscript ID: mp-2017-00497t). (accepted)